1-5 of 5
Monica Slavin
Close
Sort by
Journal Articles

Infectious Complications of Bispecific Antibody Therapy in Patients with Multiple Myeloma

Beatrice Z Sim, Anthony Longhitano, Jeremy Er, Simon J Harrison, Monica Slavin, Benjamin W Teh
Journal: Blood
Blood (2022) 140 (Supplement 1): 4384–4385.
https://doi.org/10.1182/blood-2022-167834
Published: 2022
Journal Articles

High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation

Genevieve Douglas, B.App.Sc MBBS FRACP FRCPA, Michelle K Yong, MBBS, FRACP, MPH, PhD, Shio Yen Tio, MBBS, FRACP, Maggie Chau, BPharm(Hons) MClinPharm MBusMgt BCOP, Joe Sasadeusz, MBBS FRACP PhD, Monica Slavin, MBBS FRACP, Mingdi Xie, BNurs GradDip, David Ritchie, MB ChB, PhD FRACP, FRCPA, Lynette C.Y. Chee, MBBS,PhDFRACP,FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-141764
Published: 2020
Journal Articles

The Economic and Health Utilization Cost of Clinically Significant Cytomegalovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Michelle K Yong, MBBS, FRACP, MPH, PhD, Shio Yen Tio, MBBS, FRACP, Jake Valentine, BBioMedSc, Joe Sasadeusz, MBBS FRACP PhD, Lynette C.Y. Chee, Ashish Bajel, MBBS, FRACP, FRCPA, David Ritchie, MD PhD, Monica Slavin, MBBS FRACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 3437.
https://doi.org/10.1182/blood-2019-128227
Published: 2019
Journal Articles

The Frequency of Cytomegalovirus (CMV)-Specific CD8+ T Cells Distinguishes CMV Clinical Outcomes Following Hematopoietic Allogeneic Stem Cell Transplant: A Prospective Multicentre Cohort Study

Michelle K Yong, Monica Slavin, David S. Ritchie, MDPhD, Andrew Spencer, Paul U Cameron, Orla Morrissey, Allen Cheng, Assia Samri, Guislaine Carcelain, Brigitte Autran, Sharon R Lewin
Journal: Blood
Blood (2015) 126 (23): 4312.
https://doi.org/10.1182/blood.V126.23.4312.4312
Published: 2015
Journal Articles

Incidence, Natural History and Management of Cytomegalovirus (CMV) Dnaemia and Disease in Patients with Haematological Malignancies in the Non-Allogeneic Transplantation Setting.

John Francis Seymour, MBBS, FRACP, Ashley Ng, MBBS, BMedSci, Leon Worth, MBBS, Monica Slavin, MBBS, FRACP, H. Miles Prince, MBBS, FRACP, Karin Thursky, MBBS, FRACP
Journal: Blood
Blood (2004) 104 (11): 3837.
https://doi.org/10.1182/blood.V104.11.3837.3837
Published: 2004